| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $103.88M | - | |
| Dir | 1.55M | $82.12M | - | |
| Dir | 1.19M | $62.87M | - | |
| CFO | 1.12M | $59.07M | - | |
| VP | 594.7K | $31.44M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2019 | Papadopoulos Stelios53 | Director | Sale+OE | 26,250 | $21.25 | $557,812.50 | -2.5% | |
| Feb 20, 2019 | Willsey Lance | Director | Sale+OE | 26,250 | $21.11 | $554,137.50 | -5.9% | |
| Feb 19, 2019 | Cohen Charles | Director | Sell | 248,180 | $22.14 | $5,494,906.40 | -55.8% | |
| Feb 15, 2019 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 123,000 | $21.76 | $2,676,600.00 | -16.3% | |
| Feb 14, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $22.39 | $895,654.00 | -18.2% | |
| Feb 14, 2019 | Feldbaum Carl B47 | Director | Sale+OE | 50,500 | $22.03 | $1,112,515.00 | -76.8% | |
| Feb 11, 2019 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 1,000 | $21.30 | $21,300.00 | -1.0% | |
| Feb 1, 2019 | Scangos George A77 | Director | Sell | 40,000 | $23.53 | $941,200.00 | -2.9% | |
| Jan 30, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $23.12 | $924,800.00 | -30.8% | |
| Jan 16, 2019 | Morrissey Michael | President And CEO | Sale+OE | 40,000 | $23.29 | $931,456.00 | -18.1% |